Howard Schulman

Principal investigator, leads ALLOSTEROS THERAPEUTICS, INC..

BiotechFounder

Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.

2016First federal award

$492KFederal grants as PI2 awards

0Patents grantedNone matched

0PapersOpenAlex

Career record

Federal awards and patents by year

20162017

AwardsPatents

Federal awards as principal investigator

2 awards · $492K

Date	Agency	Award	Amount	Company
Sep 18, 2017	NIH	SBIR Phase I Advancing Allosteric CaMKII Inhibitors to Treat Multiple Novel Pathways in Diabetes	$243K	ALLOSTEROS THERAPEUTICS, INC.
Jan 11, 2016	NIH	SBIR Phase I Optimizing active site inhibitor of CaMKII: A Novel Target in Atrial Fibrillation	$249K	ALLOSTEROS THERAPEUTICS, INC.

Among 4,078 researchers in Biotech

Peer ranks

Federal funding#2,454

Awards as PI#1,252

Patents#273

From filings, awards and patents

Companies

ALLOSTEROS THERAPEUTICS, INC.Leads (SEC Form D) · Biotech

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.